Mongolia Progress Report Dr. D. Otgontsetseg, Head of recording and reporting unit, TB surveillance and research department, NCCD The ninth Technical Advisory.

Slides:



Advertisements
Similar presentations
HIV/ AIDS - Yemen Successes and challenges Dr. Fouzia Abdullah Gharama Programme Manager Ministry of Public Health & Population.
Advertisements

DOTS/ DOTS PLUS IMPLEMENTATION AND INTEGRATION Vaira Leimane State Centre of Tuberculosis and Lung Diseases of Latvia Paris, October, 28.
Planning in line with the Stop TB Strategy and the Global Plan to Stop TB, Dr Win Maung Programme Manager National Tuberculosis Programme Ministry.
Improving diagnosis TB laboratory strengthening.
Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
Washington D.C., USA, July 2012www.aids2012.org A National Program Manager’s Perspective on HIV/TB Integration Dr Owen Mugurungi Director – AIDS.
Systematic TB Screening: Philippine Experience The 9th Technical Advisory Group and National TB Program Mangers meeting for TB control in the Western Pacific.
Accelerating PMDT scale up in Ethiopia
Dr R.Reesaul Chest Physician Chest Clinic P. D`or Hospital
Country Progress Report Philippines
Introduction Thailand one of 22 countries which contain 80% of the estimated tuberculosis (TB) cases in the world. Thailand ranks 17 th among the 22 high-burden.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Country Progress Report VIET NAM
World Health Organization, Western Pacific Regional Office Session 7 Empowering patients / civil society organizations Dr Cornelia Hennig Stop TB and Leprosy.
Country Progress Report LAO PDR
Early and Improved TB case detection through the use of GeneXpert technology in Nepal.
The ninth Technical Advisory Group and National TB Managers meeting
Technical Advisory Group meeting, WHO/WPRO
China TB Control Progress Report The ninth Technical Advisory Group and National TB Programme Managers meeting for TB control in the Western Pacific Region.
Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.
1 Global and Regional Tuberculosis (TB) update ACSM workshop, Amman, Jordan April 13-17, 2008 Dr. Sevil Huseynova.
Concept Note on HIV Mongolia Process and key components of Funding Request to Global Fund.
African Business Leaders on Health GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 2010 Technical Assistance.
MDR-TB: a fight we cannot afford to lose! Alexander Golubkov, MD, MPH Senior TB Technical Advisor.
1 TB/HIV Project in the Philippines Yumiko Yanase.
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
Prevention and improved treatment of communicable diseases (HIV/AIDS and TB), including increasing preparedness for bioterrorism and epidemics Anneli Taal,
FINANCIAL OPTIONS FOR TB CONTROL IN MONGOLIA
Multi-drug resistant tuberculosis: Progress and challenges in South Africa Dr S. Moyo HIV/AIDS, Sexually Transmitted Infections and TB research (HAST)Programme.
“World TB day and TB in Mongolia”
World Health Organization Regional Office for the Western Pacific Strengthening TB surveillance: regional perspective Tom Hiatt Stop TB and Leprosy Elimination.
Progress of the Singapore TB Elimination Programme (STEP)
Session 11: MDR & XDR-TB: How Can Business Help Stem the Tide?
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
Dr. Hind E. Satti Partners In Health, Lesotho March, 2008.
Japan Dr. Ismail M. Aboshama Zidan Surveillance Coordinator of NTP-Egypt Action Plan to Strengthen Laboratory Diagnostic.
1 Oct 2005 WHO/STB/THD World Health Organization 4 th Meeting of Subgroup on laboratory capacity strengthening Paris, France, October Ernesto Jaramillo.
NATIONAL TB 2012 INDICATOR ANALYSIS REPORT Presented by: Sandile Ginindza Lugogo Sun Hotel 05 th -7 th June 2013 Ministry of Health NTCP.
TB/HIV COLLABORATION IN GHANA Dr. Nii Nortey Hanson – Nortey National TB Control Programme Accra.
PMDT expansion is first of all expansion of DR-TB detection services Workshop on the development and implementation of supervision and patient support.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
1 DEWG meeting October 2009 Human Resource Development for TB Control (HRD-TB) Sub Group within the DEWG of the Stop TB Partnership. Wanda Walton.
Country Progress Report (Papua New Guinea) The ninth Technical Advisory Group and National TB Programme Managers meeting for TB control in the Western.
PERSPECTIVES FROM THE FIELD DR LYDIA MUNGHERERA TASO (The Aids Support Organisation) UGANDA REVERSING THE TIDE OF TB.
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
National Tuberculosis Control Program in Bangladesh : Progress Report Dr. Shamim Sultana Deputy Programme Manager, TB National TB Control Programme.
Exploring financing options NATIONAL TB CONTROL OF VIETNAM.
Contribution of operational research in China National Center for TB Control and Prevention, China CDC Jiang Shiwen Cancun.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
Introduction of outpatient care for DS-/MDR-TB patients in Tajikistan Cape Town, December 02-06, 2015.
Dr Ral Antic Chair Scientific Committee IUATLD-APR Australia Pre-Conference Workshop 1 National TB Control Program Summary & Remarks.
World Health Organization Regional Office for the Western Pacific Drug-resistant tuberculosis in the WHO Western Pacific Region Tauhid Islam Stop TB and.
ARV Treatment Scale Up: Progress in Ukraine Andriy Klepikov Executive Director, International HIV/AIDS Alliance in Ukraine ARV Treatment Scale Up: Progress.
Gap Analysis: Tuberculosis Care in Malawi Round 11 proposal to the Global Fund to Fight AIDS, Tuberculosis and Malaria Africa 3: Team Malawi Arianna, Babatunde,
PMDT IN CHINESE TAIPEI ECONOMY Anita Pei-Chun Chan, MD, PhD Medical Officer, TCDC Associated Director, TB Research Center, TCDC Assistant Professor, Institute.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Challenges and Constraints for TB Control in Kenya Dr. James Nyikal Director of Medical Services, Kenya.
Stop TB in China Challenges, Constraints & Actions Dr Wang Longde Vice Minister of Health China 24 March 2004.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
CAMBODIA Application to the Global Fund New Funding Model Tom Hiatt Global TBTEAM meeting June 2014.
TB- HIV Collaborative activities in Romania- may 2006 status
Prisons and TB in Europe
Country Progress Report Cambodia
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
Knowledge gaps in formulating TB Control Policies for Prisons
Key issues in DOTS implementation
World Tuberculosis Day 2016
Update on SBCC Activities of Challenge TB Bangladesh
Vietnam Investment and Finance for TB
The STOP TB Strategy – 2009 VISION: A TB-free world
Presentation transcript:

Mongolia Progress Report Dr. D. Otgontsetseg, Head of recording and reporting unit, TB surveillance and research department, NCCD The ninth Technical Advisory Group and National TB Programme Managers meeting for TB control in the Western Pacific Region Manila, Philippines December 2014

Notified all form TB cases, In Mongolia, GF project started DOTS implemented Nationwide screening

Number of smear positive TB cases, in Mongolia,

Age distribution of all forms of TB cases, in Mongolia,

Cure rate among smear positive pulmonary cases Mongolia, year

Failure and default rate among smear positive pulmonary patients Mongolia, year

Major successes  The global Millennium Development goal and regional targets for TB control are likely to be met  Increasing Government funding for TB control  Revised National TB care guidelines approved by Health Ministerial order  WHO revised definition and reporting framework for tuberculosis introduced in all levels of TB care – pilot in 2014, starting will be reported officially  Nationwide TB prevalence survey started in Apr 2014 and field data collection completed in urban areas  Introduction and roll out of GeneXpert

Major challenges  Dependence from external funding – sustainability of the National TB programme after the end of the GF grant  Diagnosis and management of EPTB and TB in children  Early detection and treatment of TB among high risk groups (homeless, alcoholics, migrants)  Increasing rates of default and failure among TB patients in the last two years, especially in Ulaanbaatar city  Lack of awareness of the public about TB

National TB Strategy/Policies Timeframe: Targets: by 2015, reduce TB prevalence to 154 per and by 2015, reduce TB mortality to 15 per Alignment with WHO End TB strategy: The new National Stop TB strategy will be developed in 2015 National Health Sector Plan will be end in National Strategic Plan to Stop TB is aligned. Budgeted 70% - GF supported project, 30% - government

Laboratory strengthening LED 2 LED: NRTL and 1 province A prison hospital and 3 provinces received in Nov 2014 Xpert 3 GeneXpert –NRTL and 2 provinces NRTL: Total tested 2659, MTB detected 50.2%, error 3.1%, rif resistance detected 18.6% Quality assurance EQA SSM 36 ZN, 1 LED labs, EQA DST, SSM from RIT, Japan Laboratory information management system Internet-based system TA partners SRL –RIT, Japan since 2005

Reach the unreached Active case finding: among high risk populations – prisoners, homeless, medical workers, pregnant women, people living with HIV Passive case finding: adults by smear examination and X-ray, children tuberculin skin test and X-ray Contact investigation: family members of smear positive patients, children, MDR-TB – target 100%, in practice – 86% TB-HIV: screening of people living with HIV for TB by Gene Xpert, all new and relapse TB cases (16 years old and above) tested for HIV. So far 181 HIV cases are reported, out of them 31 are co- infected Child TB: Operational research on contact investigation, strategy on child TB will be developed in 2015

Surveillance Quality of surveillance system –Use of national unique ID –Paper and internet based reporting: on time by paper; some difficulties using internet-based system due to internet connection New case definition roll out –WHO revised definition and reporting framework for tuberculosis introduced in all levels of TB care – pilot in 2014, starting will be reported officially

Surveillance e-R&R –Internet based reporting – ‘tubis’; –Update of the system based on WHO new definitions –90% of TB reporting units use ‘tubis’ platform Analysis and usage of data at national and sub-national levels –Analysis data at the national level on monthly, quarterly and annual basis –Limited capacity at the sub-national level

Notified (n=1375) and died (n=325) MDR-TB cases Mongolia,

Treatment success for MDRTB patients Mongolia,

Number of XDR-TB cases XDRTB Pre XDRTB total 4058 out of them: Died30 Address unclear4 Refused2 Waiting on treatment2 2 nd line treatment continued1 Cured1

PMDT Plan vs universal coverage –In 2014 planned 219 MDR-TB and 81 PDR patients to enroll in treatment Barriers –Lack of social support for MDR-TB patients –Lack of experienced health providers ( high turn over of staff) –Lack of management of side effects –Some MDR-TB patients refuse to receive treatment due to various reasons (religious, co-morbidities etc.)

PMDT: Priority actions –Strengthening management of MDR-TB patients (counseling, follow up of patients, capacity building of TB providers) –Establishment of patient support groups in collaboration with MATA –Treatment of XDR-TB patients with financial support of the GF –DRS planned in 2015 –TB prevalence survey results to be analyzed –Advocacy to include MDR-TB drugs in Government budget

Bold policies and supportive systems TB care financing and social protection –TB care financed by the Government –No health insurance coverage for TB services –No specific social protection services for TB patients –Within general social protection system TB patients (especially employed) may receive disability benefits for certain period Strengthening notification mechanism –An estimated 15-20% of diagnosed TB cases are not notified –Supportive supervision should be strengthened –Strengthen internet based reporting and recording Drug regulations – Progress since drug regulation meeting in March 2014 –New drugs for MDR-TB were included in national essential drug list –Drug information is in the process of revision in internet-based system

Patient centred care: involvement of patients and civil society Community mobilization activities –Patient support groups will be established by MATA with financial support of Stop TB Partnership CBO involvement and their role – MATA: lunch DOT and home DOT –World vision: TB services for prisoners, homeless –TB Coalition: advocacy for local governments

Patient centred care: involvement of patients and civil society Involvement of patient groups in TB control –In the process of establishment Forms of social support to TB patients (incentives? TB Pension? Reimbursement of costs related to care like transportation costs?) –Transportation cost only for MDR-TB patients (GF) –Within general social protection system TB patients (especially employed) may receive disability benefits for certain period

Thank you for your attention